Anbio Biotechnology (NNNN) Cash & Equivalents (2023 - 2025)
Historic Cash & Equivalents for Anbio Biotechnology (NNNN) over the last 3 years, with Q2 2025 value amounting to $5348.5 billion.
- Anbio Biotechnology's Cash & Equivalents changed N/A to $5348.5 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $5348.5 billion, marking a year-over-year change of. This contributed to the annual value of $11.8 million for FY2024, which is 2139.65% up from last year.
- According to the latest figures from Q2 2025, Anbio Biotechnology's Cash & Equivalents is $5348.5 billion.
- Anbio Biotechnology's Cash & Equivalents' 5-year high stood at $5348.5 billion during Q2 2025, with a 5-year trough of $9.7 million in Q4 2023.
- Its 3-year average for Cash & Equivalents is $1782.8 billion, with a median of $11.8 million in 2024.
- Over the last 5 years, Anbio Biotechnology's Cash & Equivalents had its largest YoY gain of 2139.65% in 2024, and its largest YoY loss of 2139.65% in 2024.
- Over the past 3 years, Anbio Biotechnology's Cash & Equivalents (Quarter) stood at $9.7 million in 2023, then grew by 21.4% to $11.8 million in 2024, then soared by 45476935.31% to $5348.5 billion in 2025.
- Its last three reported values are $5348.5 billion in Q2 2025, $11.8 million for Q4 2024, and $9.7 million during Q4 2023.